MediciNova Inc expected to post a loss of 6 cents a share - Earnings Preview

Medicinova

07/08/2026 22:01

MediciNova Inc MNOV.OQ MNOV.O is expected to  show a fall in quarterly revenue when it reports  results on August 11 (estimated) for the period ending June 30 2026
The La Jolla California-based  company is expected to report a 62.9% decrease in revenue to $50 thousand from $134.6 thousand a year ago, according to the mean estimate from 3 analysts, based on LSEG data.
​LSEG's mean analyst estimate for MediciNova Inc is for a loss of 6 cents per share. 
The current average analyst rating on the shares is "buy" and the breakdown of recommendations is 3 "strong buy" or "buy," no "hold" and no "sell" or "strong sell."  
The mean earnings estimate of analysts was unchanged in the last three months. ​
Wall Street's median 12-month price target for MediciNova Inc is $10.00, about 635.3% above its last closing price of $1.36
Previous quarterly performance (using preferred earnings measure in US dollars). ​
QUARTER ENDING
STARMINESMARTESTIMATE®
LSEG IBES ESTIMATE 
ACTUAL
BEAT, MET, MISSED
SURPRISE %
Mar. 31 2026
-0.07
-0.07
-0.05
Beat
28.6
Dec. 31 2026
-0.07
-0.09
-0.05
Beat
47.4
Sep. 30 2025
-0.10
-0.06
Beat
40​
Jun. 30 2025
-0.07
-0.09
-0.07
Beat
26.3
​​Mar. 31 2025
-0.14
-0.14
-0.06
Beat
57.1
Dec. 31 2024
-0.05
-0.05
-0.06
Missed
-9.1​
Sep. 30 2024
-0.06
-0.06
Met
0
Jun. 30 2024
-0.06
-0.05
Beat
16.7
This summary was machine generated August 7 at 21:01 GMT.  All figures in US dollars unless otherwise stated. (For questions concerning the data in this report, contact Estimates.Support@lseg.com. For any other questions or feedback, contact RefinitivNewsSupport@thomsonreuters.com)